Table of Contents United States RNA-based Biopharmaceuticals Market Report 2018 1 RNA-based Biopharmaceuticals Overview 1.1 Product Overview and Scope of RNA-based Biopharmaceuticals 1.2 Classification of RNA-based Biopharmaceuticals by Product Category 1.2.1 United States RNA-based Biopharmaceuticals Market Size (Sales Volume) Comparison by Type (2013-2025) 1.2.2 United States RNA-based Biopharmaceuticals Market Size (Sales Volume) Market Share by Type (Product Category) in 2017 1.2.3 Therapeutics 1.2.4 Vaccines 1.3 United States RNA-based Biopharmaceuticals Market by Application/End Users 1.3.1 United States RNA-based Biopharmaceuticals Market Size (Consumption) and Market Share Comparison by Application (2013-2025) 1.3.2 Cancer 1.3.3 Diabetes 1.3.4 Tuberculosis 1.3.5 Cardiovascular Diseases 1.3.6 Others 1.4 United States RNA-based Biopharmaceuticals Market by Region 1.4.1 United States RNA-based Biopharmaceuticals Market Size (Value) Comparison by Region (2013-2025) 1.4.2 The West RNA-based Biopharmaceuticals Status and Prospect (2013-2025) 1.4.3 Southwest RNA-based Biopharmaceuticals Status and Prospect (2013-2025) 1.4.4 The Middle Atlantic RNA-based Biopharmaceuticals Status and Prospect (2013-2025) 1.4.5 New England RNA-based Biopharmaceuticals Status and Prospect (2013-2025) 1.4.6 The South RNA-based Biopharmaceuticals Status and Prospect (2013-2025) 1.4.7 The Midwest RNA-based Biopharmaceuticals Status and Prospect (2013-2025) 1.5 United States Market Size (Value and Volume) of RNA-based Biopharmaceuticals (2013-2025) 1.5.1 United States RNA-based Biopharmaceuticals Sales and Growth Rate (2013-2025) 1.5.2 United States RNA-based Biopharmaceuticals Revenue and Growth Rate (2013-2025) 2 United States RNA-based Biopharmaceuticals Market Competition by Players/Suppliers 2.1 United States RNA-based Biopharmaceuticals Sales and Market Share of Key Players/Suppliers (2013-2018) 2.2 United States RNA-based Biopharmaceuticals Revenue and Share by Players/Suppliers (2013-2018) 2.3 United States RNA-based Biopharmaceuticals Average Price by Players/Suppliers (2013-2018) 2.4 United States RNA-based Biopharmaceuticals Market Competitive Situation and Trends 2.4.1 United States RNA-based Biopharmaceuticals Market Concentration Rate 2.4.2 United States RNA-based Biopharmaceuticals Market Share of Top 3 and Top 5 Players/Suppliers 2.4.3 Mergers & Acquisitions, Expansion in United States Market 2.5 United States Players/Suppliers RNA-based Biopharmaceuticals Manufacturing Base Distribution, Sales Area, Product Type 3 United States RNA-based Biopharmaceuticals Sales (Volume) and Revenue (Value) by Region (2013-2018) 3.1 United States RNA-based Biopharmaceuticals Sales and Market Share by Region (2013-2018) 3.2 United States RNA-based

List of Tables and Figures Figure Product Picture of RNA-based Biopharmaceuticals Figure United States RNA-based Biopharmaceuticals Market Size (K Units) by Type (2013-2025) Figure United States RNA-based Biopharmaceuticals Sales Volume Market Share by Type (Product Category) in 2017 Figure Therapeutics Product Picture Figure Vaccines Product Picture Figure United States RNA-based Biopharmaceuticals Market Size (K Units) by Application (2013-2025) Figure United States Sales Market Share of RNA-based Biopharmaceuticals by Application in 2017 Figure Cancer Examples Table Key Downstream Customer in Cancer Figure Diabetes Examples Table Key Downstream Customer in Diabetes Figure Tuberculosis Examples Table Key Downstream Customer in Tuberculosis Figure Cardiovascular Diseases Examples Table Key Downstream Customer in Cardiovascular Diseases Figure Others Examples Table Key Downstream Customer in Others Figure United States RNA-based Biopharmaceuticals Market Size (Million USD) by Region (2013-2025) Figure The West RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025) Figure Southwest RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025) Figure The Middle Atlantic RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025) Figure New England RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025) Figure The South of US RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025) Figure The Midwest RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025) Figure United States RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate (2013-2025) Figure United States RNA-based Biopharmaceuticals Revenue (Million USD) and Growth Rate (2013-2025) Figure United States RNA-based Biopharmaceuticals Market Major Players Product Sales Volume (K Units) (2013-2018) Table United States RNA-based Biopharmaceuticals Sales (K Units) of Key Players/Suppliers (2013-2018) Table United States RNA-based Biopharmaceuticals Sales Share by Players/Suppliers (2013-2018) Figure 2017 United States RNA-based Biopharmaceuticals Sales Share by Players/Suppliers Figure 2017 United States RNA-based Biopharmaceuticals Sales Share by Players/Suppliers Figure United States RNA-based Biopharmaceuticals Market Major Players Product Revenue (Million USD) (2013-2018) Table United States RNA-based Biopharmaceuticals Revenue (Million USD) by Players/Suppliers (2013-2018) Table United States RNA-based Biopharmaceuticals Revenue Share by Players/Suppliers (2013-2018) Figure 2017 United States RNA-based Biopharmaceuticals Revenue Share by Players/Suppliers Figure 2017 United States RNA-based Biopharmaceuticals Revenue Share by Players/Suppliers Table United States Market RNA-based Biopharmaceuticals Average Price (US